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Abstract
Benomyl and its metabolite carbendazim were reported to induce reproductive and 
developmental toxicity and endocrine-disrupting activity in rats. The exactly underlying 
mechanism of reproductive and developmental toxicity and endocrine-disrupting activ-
ity still remain unclear. Based on our unpublished data it showed that the antiandrogen 
flutamide can completely recover the reproductive and developmental toxicity including 
embryolethality induced by benomyl and carbendazim in rats. This manuscript aimed 
to review and generalize the results based on our previous reports. Androgen receptor 
might play an important role in benomyl- and carbendazim-induced reproductive and 
developmental toxicity and endocrine-disrupting activity. The evidences were (1) andro-
gen- and androgen receptor-dependent mechanisms are possibly involved in carben-
dazim-induced toxicity; (2) carbendazim exposure in utero displays a transient and weak 
androgenic effect and reduces flutamide antiandrogenicity in male rats; (3) antagonistic 
effect of flutamide on the carbendazim-androgenic effect on mRNA and protein levels; 
(4) benomyl and carbendazim exhibit an androgenic effect, leading to increase weight 
of ventral prostate and seminal vesicles and uterine fluid retention in young adult rats. 
The molecular underlying mechanism of reproductive and developmental toxicity and 
endocrine-disrupting activity induced by benomyl and carbendazim through androgen 
receptor need to be further investigated.
Keywords: benomyl, carbendazim, reproductive and developmental toxicity, 
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1. Introduction
As reported carbendazim (methyl-2-benzimidazole carbamate) is used to be a systemic fungicide [1]. 
Both carbendazim and its parent benomyl [methyl 1-(butylcarbamoyl)-2-benzimidazole carba-
mate] are exhibiting low acute toxicity [2]. In contrast, carbendazim and benzimidazole chemicals 
induced severe reproductive and developmental toxicity in rodents [3–6]. Reports showed that 
carbendazim and benomyl exhibited testicular toxicity such as sloughing of immature spermatids 
[7, 8], inhibition of microtubule assembly [9], seminiferous tubular atrophy [10], and testicular atro-
phy and infertility [11] in male rats. Both carbendazim and benomyl induced developmental toxic-
ity in rodents. Prenatal treatment of carbendazim to rats during pregnancy exhibited embryonic 
death, growth retardation, and developmental abnormalities including exencephaly, microph-
thalmia and hydronephrosis in offspring [3, 12]. Treatment of benomyl to pregnant rats induced 
craniocerebral and systemic malformations such as cleft palate, hydrocephalus, and exencephaly 
in offspring of male and female rats [13]. In contrary to the more reports available on the reproduc-
tive and developmental toxicity of carbendazim and benomyl, studies for endocrine-disrupting 
activity or mode of action of the these two fungicides remains unclear. The earlier report on endo-
crine activity for carbendazim might be Rehnberg et al. (1989). They showed that administration of 
male rats with carbendazim raised testosterone concentration and the levels of androgen binding 
protein in the interstitial and seminiferous tubule fluid, meaning an association between endo-
crine disruption activity and carbendazim toxicity [14]. Recently Rama et al. (2014) reviewed and 
reported that carbendazim induced reproductive toxicity and possible hormonal effects in rats [15]. 
They reviewed the previous reports and generalized that carbendazim have androgenic effects 
acting directly in the androgen receptors and/or increasing the expression of androgen receptors. 
Some chemicals were reported to increase or decrease AR expression. Bisphenol A was reported 
to increase AR expression [16] while di-n-butyl phthalate (DBP) [17, 18] and sodium valproate [19] 
decrease it. We found out that it is common for estrogen receptor agonist and androgen receptor 
antagonist but not for androgen agonist in pesticides. Based on the chemical structure it seems to 
determine the AR agonist or antagonist. The degree of increase or decrease of AR expression might 
be depended on the chemical structure, which shared with nature ligand dihydrotestosterone. 
This manuscript would like to combine our unpublished data and previous studies to infer that 
androgen receptor plays an important role in benomyl- and carbendazim-induced reproductive 
and developmental toxicity and endocrine-disrupting activity in rats.
2. Previous studies of reproductive and developmental toxicity and 
endocrine-disrupting activity induced by benomyl or carbendazim
2.1. Endocrine-disrupting activity in carbendazim-induced reproductive and 
developmental toxicity in rats
2.1.1. Materials and methods
(1) Animals and related preparation
Both male and female SD rats, 3–4week old, were obtained from the National Laboratory Animal 
Breeding and Research Center, Taipei, Taiwan. All rats were kept in specific-pathogen-free 
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animal facility in Taiwan Agricultural Chemicals and Toxic Substances Research Institute, 
Taichung, Taiwan. The animal rooms were kept on a 12-h light and dark cycle, 23 ± 2°C, and 
50 ± 10% relative humidity. When they were transported to animal room, the rats were quar-
antined for at least 1 week and opened on the bases of enough body weight gain and without 
clinical signs of disease of injury. Both carbendazim and benomyl with 99% pure were a gift 
from Sinon Co., Taichung, Taiwan. These two pesticides were suspended in polyethylene 
glycol 200 and treated to animals orally by gavage in a volume of 2 ml/kg body weight, once 
daily. In reproductive toxicity studies, male rats were administered with these two pesticides 
and/or flutamide for 28 days. In developmental toxicity studies, both male and female rats 
were administered with 200 mg/kg carbendazim or 100 mg/kg benomyl for 28 days. Then the 
female rats were mated with male within each treatment group for 14 days. No treatment was 
carried out during the mating period. Pregnant dams with plug detected were kept to deliver 
the offspring at term and conception rates were calculated. All rat offspring were weaned at 
21 days postnatal and then fed up to 6 week old [20].
(2) Organ and tissue weight, morphology, and histopathological examination
Both testis and epididymis were weighed by right and left sides. The incidence of abnormal 
morphology was recorded. The half of testis or epididymis each was fixed in 10% neutral 
phosphate-buffered formalin solution for subsequent histopathological examinations. Tissues 
of testis and epididymis were processed by standard histopathological processes and stained 
using haematoxylin and eosin for light-microscopic examinations. Both testis and epididy-
mis sections were stained with the Giemsa staining periodic acid-Schiff methods and then 
counterstained using haematoxylin as reported in Simoes and Schoning [21]. Both testis and 
epididymis histology were evaluated and histopathological findings were scored according 
to Oakberg [22] and Hess [23].
(3) In vitro androgen receptor binding assay
The ligand binding assay was processed to determine the concentration of androgen receptor 
in rat tissue according to Nonneman et al. [24]. The ligand [1, 2, 3, 5, 6, 7-3H(N)]-5α-androstan-
17β-ol-3-one (dihydrotestosterone, 5α-DHT) (110–150 Ci/mmol) was obtained from NEN 
Life Science Products, Inc., Boston. Nonlabelled 5α-DHT was obtained from Sigma Chemical 
Company, St. Louis, MO, and recrystallized from ethanol prior to use. Both rat testis and epi-
didymis were homogenized in ice-cold low-salt TEDG buffer, pH 7.4, consisting of 10 mM Tris, 
1.5 mM ethylenediaminetetraacetic acid (EDTA), 10% glycerol, and 1 mM each of dithiothreitol, 
phenylmethylsulfonyl fluoride, and sodium molybdate as described by Hardy et al. [25]. Tissue 
homogenates were centrifuged at 30,000 × g for 1 h and the supernatant were processed to use 
as the low-salt extract. Before analysis, the endogenous steroids were removed from the low-salt 
extract by incubation with dextran-coated charcoal. The binding of [3H]-5α-DHT to androgen 
receptor of testis and epididymis extract each was determined by competitive inhibition bind-
ing using nonlabelled 5α-DHT. Charcoal-treated testicular and epididymal extract each was 
incubated with 1 nM [3H]-5α-DHT at 4°C for 24 h. The nonspecific binding was carried out with 
incubating the extract with 100-fold excess nonlabelled 5α-DHT. Unbinding [3H]-5α-DHT was 
isolated from the binding steroid by adding the extract to packed hydroxyapatite in the low-salt 
TEDG buffer. Mixture were incubated for 30 min with several mixings and then centrifuged at 
600 × g for 3 min at 4°C. After that the supernatant was aspirated. An aliquot of the packed HAP 
was washed 4 times with ice-cold 50 mM Tris buffer, pH 7.3. In determination of total binding, 
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the binding [3H]-5α-DHT was extracted from HAP with ethanol and counted for radioactivity 
using a Beckman model LS6000 TA liquid scintillator. For specific binding of testis and epi-
didymis extracts they were determined by subtracting nonspecific binding from total binding 
and corrected for protein concentration. The protein concentration was determined according 
to Lowry et al. [26]. Analysis of effect of carbendazim on androgen receptor binding, specific 
binding of [3H]-5α-DHT to testis extract was carried out with incubation of the charcoal-treated 
testis extract with [3H]-5α-DHT in the presence of carbendazim at 4°C for 24 h. Incubation mix-
tures were carried out to the same procedures as before in the androgen receptor binding assay.
(4) Statistical analysis
All these data were expressed as mean ± SE. All data were processed to analysis of variance 
followed by Student’s t-test. The level of significance was set at p < 0.05.
2.1.2. Abstract
This study aimed to investigate the endocrine-disrupting activity of carbendazim-induced repro-
ductive and developmental toxicity in rats. The male rats were co-treatment with 675 mg/kg 
carbendazim and 50 or 100 mg/kg flutamide, an androgen receptor antagonist, once daily for 
28 days decreased testis weight induced by treatment with carbendazim alone. Co-treatment of 
carbendazim and flutamide blocked losses of spermatozoa and cell morphology and decrease of 
sperm concentration induced by carbendazim. An important evidence for endocrine disrupting 
activity induced by carbendazim and benomyl was that premating treatment of male and female 
rats with 200 mg/kg carbendazim for 28 days resulted in androgenic effects including incomplete 
development of uterine horn, enlargement of urethra, absence of vagina, and induction of semi-
nal vesicles in female offspring, without significant effects in male offspring. Also, premating 
treatment with 100 mg/kg benomyl, the parent compound of carbendazim, produced incom-
plete development of uterine horn and absence of vagina in female offspring and induced testis 
and epididymis atrophy in male offspring. When male rats were treated with 25, 50, 100, 200, 
400, and 800 mg/kg carbendazim for 56 days androgen receptor concentrations were increased 
in testis and epididymis with dose dependent. Furthermore, additions of 5, 50, and 500 M car-
bendazim to testis extract from untreated rats substituted binding of [3H]5 -dihydrotestosterone 
to androgen receptor with concentration dependent. This study illustrated that reproductive 
toxicity exhibited by carbendazim is relieved by an androgen receptor antagonist flutamide in 
male rats and developmental toxicity of the fungicide shows androgenic properties in female off-
spring. The authors concluded that androgen- and androgen receptor-dependent mechanisms 
are quite possibly involved in carbendazim-induced toxicity.
2.2. Antagonistic and synergistic effects of carbendazim and flutamide exposures in 
utero on reproductive and developmental toxicity in rats
2.2.1. Materials and methods
(1) Animals and related preparation
Both male and female rats were obtained from the National Laboratory Animal Center, Taipei, 
Taiwan. All rats were kept in specific pathogen-free animal facility in Taiwan Agricultural 
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Chemicals and Toxic Substances Research Institute, Taichung, Taiwan. All animal rooms were 
kept under a 12-hour light and dark cycle, 23 ± 2°C, and 50 ± 10% relatively humidity. All 
animal had access ad libitum to reverse osmosis water and rodent chow (LabDiet® 5001, PMI 
Nutrition International, LLC, Brentwood, MO, USA). When the animals were transported 
to the animal room, all rats were quarantined for at least 1 week and opened on the basis of 
enough body weight and without clinical signs of disease or injury. Female rats were mated 
with male within each same treatment group for 14 days. Gestation day (GD 0) was defined 
as the day that sperm was detected in vagina of the mated female. Allocating animals to 
treatment groups was finished on the basis of body weight randomization to ensure unbiased 
weight distribution across groups. Dams and offspring were kept in polycarbonate cages on 
Laboratory Animal Bedding (TCP Chipsi Heimtier Steu, Germany) until weaning postna-
tal day 21 (PND 21), at which the test animals were housed, up to 5 per cage, by sex and 
treatment until necropsy on PND 56. All male and female offspring were euthanized by CO
2
 
asphyxiation and processed to subsequent postmortem examination [27].
(2) Treatment and dose design
Both carbendazim and benomyl with 99% pure were a gift from Sinon Co., Taichung, Taiwan. 
All other chemicals were purchased from Sigma (St. Louis, MO, USA) unless otherwise noted. 
Carbendazim, benomyl, or flutamide each was suspended in corn oil and treated to animals 
orally by gavage in a volume of 2.5 mL/kg body weight, once daily. Groups of five rats from 
GD 0 to 20, were treated with carbendazim at 6.25, 12.5, and 25 mg/kg; benomyl at 25, 50, and 
100 mg/kg; or flutamide at 0.6, 2.5, and 10 mg/kg. Also, rats were co-treated with 25 mg/kg 
carbendazim and 0.6, 2.5, and 10 mg/kg flutamide or co-treated with 100 mg/kg benomyl and 
0.6, 2.5 or 10 mg/kg flutamide. Female rats were checked daily for clinical signs of toxicity. 
Female body weight and food consumption were measured daily throughout dosing and 
lactation period. All rat offspring were weaned at PND 21 and fed up to 8-week-old. All rat 
organ weights were determined on PND 21. Conception rate on GD 21 and 22, proportion of 
pups born alive on PND 1, proportion of pups surviving to weaning on PND 21, and sex ratio 
on PND 56 were measured and recorded.
(3) Determination of androgen-dependent reproductive development effects
What they determined for androgen-dependent reproductive end points were signs of clinical 
toxicity, anogenital distance (AGD), male and female pup weight, retention of areolae and/or 
nipples, malformations of external genitalia, testicular descent, preputial separation, vaginal 
opening, and organ weight and malformation on PND 56 [28, 29]. All pups were counted 
and examined for signs of clinical toxicity on PND 0 and were individually identifievd by 
tail-labeling on PND 21. All pups with AGD, and live male and female offspring weights were 
measured on PND 2, 22, and 42. Day of completion of preputial separation (PPS) and body 
weight in PPS of male offspring during PND 40 and 50 were also measured. Day of onset 
of vaginal opening (VO) and body weight in VO of female offspring during PND 30 and 45 
were measured. End points of gross morphology of reproductive organs, nipple retention, 
abnormal testis and epididymis, hypospadias, underdevelopment of prostate or/and seminal 
vesicle, absent prostate or/and seminal vesicle, bladder stone, and underdevelopment of leva-
tor ani bulbocavernosus muscle in male offspring were determined on PND 56.
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(4) Necropsy of rats
All pups were weaned on PND 21. Rats were euthanized by CO
2
 asphyxiation. All body and 
organ/tissue weights including liver, kidneys, adrenals, uterus, ovaries, thyroids and number 
of implantation sites were measured on PND 21.
(5) Necropsy of F1 offspring
Both male and female offspring on PND 56 were euthanized by CO
2
 asphyxiation and blood 
was collected via trunk. After blood collection, the ventral surface of offspring was shaved for 
counting the number of nipples. External genitalia, including the scrotum, prepuce, and penis 
of male offspring and vaginal of female offspring were visually inspected. End points of gross 
internal examination of the reproductive tract such as inspection of the testes, epididymides, 
prostate, seminal vesicles, levator ani bulbocavernosus muscle, and penis were measured. 
Also, the liver, kidneys, adrenal glands and thyroids were grossly examined and weighed. 
Body and organ weights such as testes, epididymides, prostate, seminal vesicles with fluid, 
levator ani bulbocavernosus muscle, and penis, liver, kidneys, adrenals and thyroids were 
collected. All examined tissues were fixed in 10% neutral buffered formalin, processed, sec-
tioned, and stained with haematoxylin and eosin.
2.2.2. Abstract
Both carbendazim (methyl 2-benzimidazolecarbamate) and benomyl are reported to exhibit 
reproductive and developmental toxicity in male rats. This study was mainly to detect the ability 
of carbendazim exposure in utero to alter androgen-dependent development indicators in rat 
offspring and measure the effects of antiandrogen flutamide on the carbendazim-induced repro-
ductive and developmental alterations. All pregnant female rats were administered with 6.25, 
12.5 or 25 mg/kg carbendazim, 25, 50 or 100 mg/kg benomyl, and 0.6, 2.5 or 10 mg/kg flutamide 
by gavage once daily from gestational day 0 to 20. Also, group of female rats was co-treated with 
25 mg/kg carbendazim or 100 mg/kg benomyl and 0.6, 2.5, and 10 mg/kg flutamide. The results 
showed that the various treatments decreased the survival rates of pups on PND 1 and 21. For 
male offspring, 12.5 and 25 mg/kg carbendazim increased AGD, an androgen-dependent indica-
tor, on PND 2. Also, benomyl increased AGD of offspring. Co-treatment with 25 mg/kg carben-
dazim with 0.6, 2.5, and 10 mg/kg flutamide relieved the androgenic effect on AGD induced by 
carbendazim. The androgenic effects of AGD induced by carbendazim and benomyl on AGD 
were reversible on PND 22 and later. Carbendazim had no effects on other androgen-dependent 
indicators such as testis and epididymis malformations, hypospadias, nipple retention, and 
organ weights of seminal vesicle and levator ani bulbocavernosus muscle on PND 56. Quite 
surprisingly, carbendazim antagonized the antiandrogenic effects on these indicators induced 
by flutamide cotreatment. For female offspring, carbendazim exhibited synergistic effects on the 
flutamide cotreatment-mediated increases of organs weights in liver and kidney on PND 56. No 
significant effects on female reproductive organs were induced by carbendazim. These findings 
suggested that carbendazim exposure in utero exhibited a transient and weak androgenic effect 
and reduces flutamide antiandrogenicity in male rats. These two fungicides enhance flutamide-
mediated increases of liver and kidney weight in female rats. The antagonistic and synergistic 
interactions between carbendazim and flutamide in utero need to be further investigated.
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2.3. Carbendazim-induced androgen receptor expression antagonized by flutamide 
in male rats
2.3.1. Materials and methods
(1) Animals and related treatments
Male SD rats with three-week-old were obtained from the National Laboratory Animal Center, 
Taipei, Taiwan. All rats were kept in a specific-pathogen-free animal facility in the Taiwan 
Agricultural Chemicals and Toxic Substances Research Institute (TACTRI) in Taichung. The 
animal rooms were sustained at a 12-hour light and dark cycle, 23 ± 2°C and 50 ± 10% relative 
humidity. When the animals were transported to the room, the rats were quarantined for at least 
1 week and were available for test only when they exhibited enough body weight gain and no 
clinical signs of disease or injury. Carbendazim with 99% pure was obtained from Sinon Co. 
(Taichung, Taiwan). Flutamide (FLU) and the other chemicals were obtained from Sigma (St. 
Louis, MO, USA), unless otherwise stated. The pesticide was suspended in corn oil and orally 
administered to five rats in each group once a day by gavage at a volume of 2.5 mL/kg body 
weight. Male rats (322 ± 15 g) were randomly assigned to each treatment group. In order to 
carry out the time- and dose-dependent tests, the protocol included two treatment-duration and 
dosages. The first one was as follows: The doses of carbendazim were 0, 25, 50, 100, 200, 400 and 
800 mg/kg/day for 56 days. The doses of flutamide were 0, 6.25, 12.5, 25, 50 and 100 mg/kg/day 
for 28 days. In mixed doses, the rats were co-treated with 675 mg/kg/day of carbendazim and 
0, 6.25, 12.5, 25, 50 and 100 mg/kg/day of flutamide for 28 days. The second one was as follows: 
The doses of carbendazim were 0, 6.25, 25, 100 and 400 mg/kg/day for 7 days, while the doses of 
flutamide were 0, 0.78, 3.13, 12.5 and 50 mg/kg/day for 7 days. The rats in the co-treatment group 
were given either 400 mg/kg of carbendazim and 0, 0.78, 3.13, 12.5 and 50 mg/kg/day of flu-
tamide, or 50 mg/kg/day of flutamide and 0, 6.25, 25, 100 and 400 mg/kg/day of carbendazim for 
7 days. All animal care and experimental procedures were approved by the Institution Animal 
Care and Use of Committee (IACUC) of TCATRI [30].
(2) Immunohistochemical (IHC) evaluation
The testes tissues of three groups of rats were tested: (1) 0, 25, 50, 100, 200, 400 and 800 
mg/kg/day of carbendazim for 56 days; (2) 0, 6.25, 12.5, 25, 50 and 100 mg/kg/day of flutamide 
for 28 days; and (3) co-treatment with 675 mg/kg/day of carbendazim and 0, 6.25, 12.5, 25, 50 
and 100 mg/kg/day of flutamide for 28 days. Testes from the following test groups were fixed 
in 10% neutral buffered formalin for 1 week. The tissues were then dehydrated with increasing 
concentrations of ethanol, cleared in toluene and embedded in paraffin. Sections were cut into 
5-mm slices and deparaffinized, hydrated and treated with 0.3% H
2
O
2
 in PBS (pH 7.6) for 30 min 
to block endogenous peroxidase activity, and finally treated with a protein-blocking solution 
(5% goat serum diluted in phosphate-buffered saline). These steps were followed by heating the 
sections in a microwave oven for antigen retrieval using a 0.01 M citrate buffer solution (pH 5.5). 
Tissue sections were immunostained with rabbit anti-AR (N-20, Santa Cruz Biotechnology, Inc., 
CA, USA), which was diluted 1: 250 in phosphate-buffered saline and 0.25% bovine serum albu-
min and maintained at room temperature overnight. The tissue sections were then developed 
with a streptavidin-HRP kit (Chemicon IHC Select® CA, USA), using diaminobenzidine as the 
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chromogen, and were counterstained with haematoxylin. All images were optimized by using 
an inverted microscope (Leica, Wetzlar GmbH, Germany). To quantify the relative amount of 
AR protein in the IHC, 200 nucleus stained per field in a slide, 5 fields per slide, 5 slides per 
dose were counted. The intensity of AR protein stained in nucleus was graded as (0, negative), + 
(1, mild), ++ (2, moderate), +++ (3, intense), ++++ (4, more intense) or +++++ (5, very intense). The 
measurements were control group adjusted and the values were statistically analyzed.
(3) Reverse transcription-polymerase chain reaction (PCR)
Testes (n = 5) from the following treatment groups were stored at −80°C for 7 days. Total 
RNA was extracted with an RNeasy® Mini Kit (QIAGEN, TAIGEN Bioscience Corporation, 
Dusseldorf, Germany) according to the protocol provided by the manufacturer. For the reverse 
transcription (RT) reaction, 3 mL of total RNA was used from the individual rats of each 
group. The RT-PCR reactions in this study were carried out with SuperScriptTM III One-Step 
RT-PCR System with Platinum® Taq DNA polymerase kits from Invitrogen (Cat. No. 12574–
026) in DNA Engine® & DNA Engine Tetrad® Peltier Thermal Cyclers (PTC-200, MJ Research, 
Incorporated, Massachusetts 02451 USA). For AR mRNA amplification, the primers were 
designed to amplify a 570-bp fragment (forward, 5’-TGCTGCCTTGTTATCTAGTCTCA-3′; 
reverse, 5’-ACCATATGGGACTTGATTAGCAG-3′) (annealing temperature, 60°C; the num-
ber of cycles, 24, 26 and 28; product size, 570 bp). PCR was subsequently performed using 
an optimized protocol of between 24 and 28 cycles. Each cycle consisted of the following: 
94°C, 30 s; 60°C, 30 s and 72°C, 45 s. For b-actin mRNA amplification, the primers were 
designed to a 359-bp fragment (forward, 5’-CTGTGCCCATCTATGAGGGTTAC-3′; reverse, 
5’-AATCCACACAGAGTACTTGCGCT-3′) (annealing temperature, 60°C; the number of 
cycles, 24, 26 and 28; product size, 359 bp). PCR was subsequently performed using an opti-
mized protocol of between 24 and 28 cycles. Each cycle consisted of the following: 94°C, 30 s; 
60°C, 30 s and 72°C, 45 s. PCR products were resolved in a 1.2% agarose gel and stained with 
ethidium bromide, and DNA bands from triplicate reactions were quantified using a FOTO/
Analyst® Investigator System (Fotodyne Incorporated, Hartland, WI, USA). The PCR prod-
ucts for β-actin served as an internal standard.
(4) Western blot
A Polytron PT3100 homogenizer (Kinematica AG, Littau, Switzerland) was used to examine fro-
zen testicular tissues from the following treatment groups. Tissues of testes from the first proto-
col were homogenized for a few seconds in an M-PER® Mammalian Protein Extraction Reagent 
(Cat. No. 78505, Pierce). The homogenates were then centrifuged at 105,000 × g for 1 h at 4°C. The 
supernatants were aliquoted and stored at −86°C before use. Before western blotting, protein 
contents were measured by BCA protein assay (Cat. No. 23225, Pierce). Equal amounts of pro-
tein were loaded onto each polyacrylamide gel. The antibody dilutions were 1: 200 for the anti-
AR antibody (N-20, Santa Cruz Co., CA) and 1: 5000 for the horseradish peroxidase conjugated 
goat anti-rabbit IgG (AP132P, Chemicon International). For each treatment group, five samples 
were analyzed in two separate blots. Total protein extracts from the testicular tissue were dena-
tured and separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
with 7.5% polyacrylamide. The proteins were transferred to nitrocellulose membranes. The 
membranes were then blocked for non-specific binding and incubated with polyclonal primary 
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antibodies for AR (N-20, Santa Cruz Co., CA) and β-actin (AP132P, Chemicon International). 
After incubation with primary antibody, the membranes were incubated with horseradish per-
oxidase-linked anti-goat IgG secondary antibody and visualized on film exposed to enhanced 
chemiluminescence (VisualizerTM Western Blot Detection Kit, Millipore, MA, USA). The relative 
amount of protein in the resulting immunoblot bands was estimated by measuring the optical 
densities of the bands on exposed films using a FOTO/Analyst® Investigator System (Fotodyne 
Incorporated, WI, USA). The measurements were background adjusted and the values were sta-
tistically analyzed. Protein for ß-actin served as an internal standard.
(5) Hormone analysis
Serum luteinizing hormone (LH) (RPN 2562, Amersham, UK), follicular stimulating hormone 
(FSH) (RPN 2560, Amersham, UK; AE R004, Biocode, Belgium), 17b-estradiol (E
2
) (Cayman 
Chemical., Ann Arbor, MI, USA) and testosterone (T) (Cayman Chemical., Ann Arbor, MI, 
USA) levels were determined using the relevant EIA systems. The serum samples collected 
from rats treated with 0, 6.25, 25, 100 and 400 mg/kg/day of carbendazim for 7 days and 
0, 0.78, 3.13, 12.5 and 50 mg/kg/day of flutamide for 7 days were directly applied to the 
well in the kit and measurements were taken according to the procedure described by the 
manufacturer.
(6) Statistical analysis
The values of AR in Western blot and RT-PCR were normalized against b-actin. All results 
were statistically analyzed with the t-test and p < 0.05 was considered statistically significant. 
The other data were expressed as mean ± SE. Data were subjected to ANOVA followed by 
t-test. The level of significance was set at p < 0.05.
2.3.2. Abstract
Carbendazim was widely used as a fungicide, and it was reported to exhibit reproductive 
and developmental toxicity. This study aimed to detect the expression of androgen receptor 
caused by carbendazim and the antagonistic effect of flutamide. Groups of five rats were 
treated with carbendazim, flutamide or a combination of both to determine androgen receptor 
mRNA, immune activity and protein expression. Carbendazim increased androgen receptor 
mRNA with dose dependent, while flutamide, an androgen receptor antagonist, blocked it. 
When co-treatment with carbendazim and various flutamide doses it decreased the andro-
gen receptor mRNA dose dependent. In contrast, co-treatment with flutamide and various 
carbendazim doses increased the androgen receptor mRNA with dose dependent. In the 
immunohistochemistry (IHC) and Western blot (WB) analyses it showed that carbendazim 
increased androgen receptor activity particular in rat testes with dose dependent, while flu-
tamide decreased it. Moreover, treatment with carbendazim or flutamide for 7 days raised 
testosterone and follicular stimulating hormone concentrations in the serum of male rats 
with dose dependent, which might involve the disruption of the androgen receptor. Despite 
the fact that we need to examine the underlying mechanism of androgen receptor involved in 
the reproductive toxicity and endocrine-disrupting activity exhibited by carbendazim and its 
parent, benomyl, we should first discuss how to take advantage of flutamide antagonism on 
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carbendazim-produced reproductive and endocrine disrupting activity possibly in human. 
This study concluded that carbendazim exhibited androgen receptor expression in mRNA 
and protein levels, while flutamide antagonized it. As we know this is the first report on the 
antagonistic effect of flutamide on the carbendazim-androgenic effect on mRNA and protein 
levels. This study would give a light way to illuminate the mechanism of carbendazim- and 
chemical-produced developmental toxicity and endocrine disrupting activity.
2.4. Detecting benomyl and its metabolite carbendazim inducing androgenic 
activity in rats by using uterotrophic and Hershberger assays
2.4.1. Materials and methods
(1) Chemicals
The following materials were obtained: testosterone propionate (TP, purity ≥97%), Sigma-
Aldrich Co. (Buchs, Switzerland); 17β-estradiol (E
2
, purity ≥98%), flutamide (Flu, purity ≥97%), 
and corn oil (0.9 g/mL), Sigma Chemical Co. (St. Louis, MO, USA); carbendazim (Mbc, purity 
≥99%), and benomyl (Ben, purity ≥99%), Sino Co. (Taichung, Taiwan, ROC) [31].
(2) Animals, experimental conditions, castration (Cast) and ovariectomy (OVX) procedures
The animal use protocol was reviewed and approved by the Institutional Animal Care and 
Use Committee (IACUC) of the Taiwan Agricultural Chemicals and Toxic Substances Research 
Institute. Four-week-old male and female SD rats were purchased from the National Laboratory 
Animal Center, Taipei, Taiwan. All rats were accustomed at least to the laboratory environment 
for 3 weeks before test. During the experiment period, all rats were kept, two to three per cage, in 
suspended aluminum cages with stainless-steel wire-mesh front and floor under the controlled 
conditions, containing a temperature of 21 ± 2°C, a relative humidity of 40–70%, a frequency of 
ventilation of more than 10 air exchanges per hour, and a 12-h light/dark cycle. Drinking water 
and pellet rodent diet were available ad libitum. Male rats at 7 weeks of age underwent Cast 
procedure. Under ether anesthesia an incision was made in the scrotum and both testes and 
epididymis were removed with ligation of blood vessels and seminal ducts. Chemical treat-
ment was not initiated until 30 days later to allow for complete recovery from surgical stress. 
Ovariectomy (OVX) procedure for female rats was operated about 7 weeks of age under ether 
anesthesia by opening the dorsolateral abdominal wall at the midpoint between the costal infe-
rior border and the iliac crest, a few millimeters from the two lateral margins of the lumbar 
muscle. On the abdominal cavity, the ovaries were located. On an aseptic field, the ovaries were 
physically removed from the abdominal cavity. A tie was operated between the ovary and 
uterus to control bleeding and the ovary was detached by incision above the tie at the junction of 
the oviduct and each uterine horn. Following the surgery, females were acclimated for 30 days 
to allow for recovery from operation stress and to monitor the estrus cycle to confirm the success 
of OVX. Only those animals in the diestrus or metestrus phase were used in the experiments.
(3) Study design and clinical examination
This study was designed according to standardized test guidelines, including OECD test 440 
[32], USEPA OPPTS 890.1600 [33], OECD test 441 [34] and USEPA OPPTS 890.1400 [35], with 
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modification of endpoints. Table 1 shows the treatment conditions for uterotrophic assay 
(estrogenic and antiestrogenic/estrogenic) and Hershberger assay (androgenic and anti-
androgenic/androgenic) in young adult rats (275 ± 15 g). Each experimental group consisted 
of six animals. Test and reference substances were suspended or dissolved daily in vehicle 
(corn oil). Daily dosages of E
2
 and TP were 2.5 ml/kg body weight (BW) administered via 
oral gavage and 0.5 ml/kg BW administered via subcutaneous injection. Oral gavage was 
selected because it is one of the potential exposure routes of test chemicals in humans. For all 
experiments, clinical signs, BW and weights of liver and kidneys were assessed as indices of 
systemic toxicity. Clinical signs including any abnormal behavior were recorded twice a day 
for each animal.
(4) Assessment of antiestrogenicity/estrogenicity in young adult rats
A 10-day uterotrophic assay using OVX rats was performed to determine if benomyl, carben-
dazim and flutamide interfere with estrogen receptor-mediated mechanisms. For assessment of 
antiestrogenicity/estrogenicity, 5 mg/kg/day E
2
 was administered daily, as a reference estrogen, 
by subcutaneous injection on the dorsal surface, as previously described [32, 33] with modified 
dosage. Benomyl, carbendazim or flutamide was administered to OVX or E
2
-treated OVX rats 
by oral gavage for 10 days. A previous study has shown that AR antagonist flutamide blocks 
the androgenic effect induced by carbendazim [27]. To investigate the effects of AR agonists 
benomyl and carbendazim (50, 100, 200, 400, and 800 mg/kg/day) and antagonist flutamide 
(6.25, 12.5, 25, 50, and 100 mg/kg/day) on estrogenic activity in rats, these chemicals were 
administered to OVX rats by oral gavage for 10 days. The dose levels of benomyl, carbendazim 
or flutamide have been previously described [20]. One day after the final administration, rats 
were euthanized by blood withdrawal from the abdominal femoral artery under light ether 
anesthesia and exhaust ventilation to maintain the airborne concentrations of vapors below 
their respective threshold values. Uterus with fluid, vagina, thymus, thyroid, liver, lung, adrenal 
glands, kidneys and bladder were examined for gross lesions and then dissected and weighed 
after careful trimming to remove fat and other contiguous tissues in a uniform manner.
(5) Assessment of antiandrogenicity/androgenicity in young adult rats
A 10-day Hershberger assay using male rats was performed to determine if benomyl, carben-
dazim and flutamide interfere with AR-mediated mechanisms. For assessment of antiandro-
genicity/androgenicity, 5 mg/kg/day testosterone propionate (TP) was administered daily, as 
a reference androgen, by subcutaneous injection on the dorsal surface as previously described 
[34–36] with modified dosage. Benomyl, carbendazim or flutamide was administered to Cast 
or TP-treated Cast rats by oral gavage for 10 days. Dosages of 50 and 100 mg/kg/day benomyl, 
carbendazim or flutamide [20] were administered as antagonist control for anti-androgenicity 
in young adult rats, as previously described. One day after the final administration, rats were 
euthanized by blood withdrawal from the abdominal femoral artery under light ether anes-
thesia and exhaust ventilation to maintain the airborne concentrations of vapors below their 
respective threshold values. The reproductive accessory glands/tissues (prostate, seminal ves-
icles with coagulating glands, levator ani plus bulbocavernosus muscles, and penis), as well as 
thymus, thyroid, lung, liver, adrenal glands, kidneys, bladder, and scrotum, were examined 
for gross lesions and dissected. All tissues were carefully trimmed to remove fat and weighed.
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Dose (mg/kg/day) Uterotrophic assay6 Hershberger assay6
Estrogenic Anti-estrogenic/
estrogenic
Androgenic Anti-androgenic/
androgenic
Treatment group1 1 2 3 4 1 2 3 4
Control (intact) +7 +
Control (OVX) 2 + -8
E
2
 (sc) 3 — — + + — — — —
Control (Cast) 4 — +
TP (sc)5 — — — — — — + +
Corn oil (oral) + — + — + — + —
Benomyl (Ben)
50 — + — + — + — +
100 — + — + — + — +
200 — + — + — — — —
400 — + — + — — — —
800 — + — + — — — —
Carbendazim (Mbc)
50 — + — + — + — +
100 — + — + — + — +
200 — + — + — — — —
400 — + — + — — — —
800 — + — + — — — —
Flutamide (Flu)
6.25 — + — + — — — —
12.5 — + — + — — — —
25 — + — + — — — —
50 — + — + — + — +
100 — + — + — + — +
1All treatment groups were treated with 6 male or 6 female rats.
2OVX: ovariectomy.
3E
2
 (sc): 17β-Estradiol, 5 mg/kg/day (subcutaneous).
4Cast: castrated.
5TP (sc): testosterone propionate, 5 mg/kg/day (subcutaneous).
6Comparison pairs for uterotrophic and Hershberger assays are as follows, respectively: treatment group 1 vs. treatment 
group 2; treatment group 3 vs. treatment group 4.
7+: with.
8−: without.
Table 1. Study design for uterotrophic and Hershberger assays.
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(6) Statistical analysis
Data are expressed as mean ± SD. BW and organ weights were subjected to ANOVA followed 
by student’s t-test. The level of significance was set at p < 0.05.
2.4.2. Abstract
The both benomyl and carbendazim are widely used systemic fungicides. It has been shown 
that benomyl and carbendazim induce endocrine-disrupting activity, resulting in reproductive 
and developmental toxicity, as well as androgen receptor (AR) gene expression in rats. The aim 
of this study was to link AR induction by benomyl and carbendazim, observed in our previous 
reports, with the results of Hershberger and uterotrophic assays. In an uterotrophic assay, nei-
ther benomyl nor carbendazim, except at 800 mg/kg/day, affected weight of uterus and vagina 
when compared to the ovariectomized control rats. Co-treatment with 17β-estradiol (E
2
) and 
200 mg/kg/day benomyl or co-treatment with E
2
 and 200, 800 mg/kg/day carbendazim signifi-
cantly increased uterine weight when compared to treatment with E
2
 alone in an uterotrophic 
assay. This uterotrophic activity might be mediated through AR. Treatment with flutamide 
alone or in combination with E
2
 had no effect on uterine weight. In the Hershberger assay, treat-
ment with 50 and 100 mg/kg/day benomyl increased weight of ventral prostate plus seminal 
vesicles. Carbendazim or flutamide alone exhibited no effect on reproductive accessory gland 
weight. Co-treatment with testosterone propionate (TP) and 50 or 100 mg/kg/day carbendazim, 
but not benomyl, significantly increased the weight of ventral prostate plus seminal vesicles. 
Co-treatment with TP and 50 or 100 mg/kg/day flutamide significantly decreased these repro-
ductive accessory gland weights when compared with TP alone. Based on our previous report, 
carbendazim increases mRNA and protein expression of AR in testis, epididymis and prostate 
and antagonizes the reduced tissue weights of seminal vesicle and prostate of male offsprings 
induced by in utero exposure to flutamide in rats. This infers that benomyl and carbendazim 
increase the weight of ventral prostate plus seminal vesicles through induction of AR expres-
sion. Moreover, according to a previous report, TP, an AR agonist, induces fluid retention in 
uterus by exhibiting androgenic activity, similar to that of benomyl and carbendazim, in an 
uterotrophic assay. Based on these results, benomyl and carbendazim exhibit an androgenic 
effect, leading to increased weight of ventral prostate and seminal vesicles and uterine fluid 
retention in young adult rats. The exact mechanisms require further investigation.
3. Future work and recommendations
OECD takes much effort to promote adverse outcome pathways (AOP) methodology. 
Androgen receptor-mediated reproductive and developmental toxicity and endocrine dis-
rupting activity would be a novel AOP. It is an approach to support the use of a mode (and/
or mechanism) of action basis for understanding the adverse effects of chemicals and other 
stressors. AR mediated reproductive and developmental toxicity and endocrine disrupting 
activity would be a novel future application. Specific molecular signals of AR mediated effects 
would be the future work.
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4. Diagram/schematic figure
In the respect of chemical structure, benomyl and carbendazim shared the same C and D 
ring structure with the natural ligand, dihydrotestosterone (Figure 1). We made a schematic 
labeling of the benomyl, carbendazim mimicking the main ligand interaction features of the 
natural ligand, dihydrotestosterone, with the androgen receptor referred to the previous 
report by Tamura et al. (2003) [37].
Figure 1. Schematic labeling of the benomyl, carbendazim mimic the main ligand interaction features of the natural 
ligand, dihydrotestosterone, with the androgen receptor.
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5. Conclusions
Based on the previous study firstly it proved that reproductive toxicity produced by car-
bendazim is relieved by an androgen receptor antagonist in male rats and developmental 
toxicity of the pesticide showed androgenic properties in female offspring. We concluded that 
androgen- and androgen receptor-dependent mechanisms are quite possibly complicated in 
carbendazim-produced toxicity. Secondly findings show that carbendazim exposure in utero 
displays a transient and weak androgenic effect and reduces flutamide antiandrogenicity in 
male rats. Thirdly we concluded that antagonistic effect of flutamide was on the carbendazim-
androgenic effect on mRNA and protein levels. The results would help us to illustrate the 
mechanism of carbendazim- and chemical-induced developmental toxicity and endocrine-
disrupting activity. Fourthly benomyl and carbendazim exhibit an androgenic effect, leading 
to increased weight of ventral prostate and seminal vesicles and uterine fluid retention in 
young adult rats.
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